INHIBITORS OF BROMODOMAINS AS MODULATORS OF GENE EXPRESSION
This disclosure relates generally to compounds and compositions comprising one or more diphenylethylene, diphenylethylyne, and azobenzene analogs. These compounds are useful for treating diseases associated with NF-kB and p53 activity, such as cancer and inflammatory disease.
-
(2012/09/11)
More Articles about upstream products of 1395084-18-0